Effect evaluation of interaperitoneal injection of bupivacaine on post-operative pain in laparascopic cholecyctectomy

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2012090910790N1

Enrollment

Registered

2012-10-24

Start date

2011-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-operative pain in laparascopic cholecyctectomy. Postcholecystectomy syndrome

Interventions

Intervention 1: intervention group received, 0.5mg/kg intraperitoneal Bupivacain 0.25 % after Laparascopic cholecystectomy. Intervention 2: control group received 0.5 cc/kg , normal salin after Lapara

Treatment - Drugs

intervention group received, 0.5mg/kg intraperitoneal Bupivacain 0.25 % after Laparascopic cholecystectomy

control group received 0.5 cc/kg , normal salin after Laparascopic cholecystectomy

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 20-60 years old patients selected by American Society of Anesthesiologists (ASA) sorting. Exclusion criteria: Total Body Weight (TBW) <50 kg; chronic pain or using opioid (in recently month); history of abdominal aneurysm.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: 0,1,2,8,12,24 hours after operation. Method of measurement: NRS.	—

Secondary

Measure	Time frame
Shoulder pain. Timepoint: 0,1,2,8,12,24 hours after operation. Method of measurement: NRS.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Nozar Nasajian

Ahwaz Jundishapour University of Medical Sciences

nozar-dr@yahoo.com+98 6116193673166

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026